Fortress Biotech
(NASDAQ) FBIOP
Fortress Biotech Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$62.30M
Net Income (TTM)
$3.99M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.28 (Low)
Dividend
$0.00
Beta (Volatility)
0.28 (Low)
Price
$13.39
Volume
15,030
Open
$13.52
Price
$13.39
Volume
15,030
Open
$13.52
Previous Close
$13.22
Daily Range
$13.21 - $13.59
52-Week Range
$4.72 - $14.64
Dividend
$0.00
Beta (Volatility)
0.28 (Low)
Price
$13.39
Volume
15,030
Open
$13.52
Previous Close
$13.22
Daily Range
$13.21 - $13.59
52-Week Range
$4.72 - $14.64
FBIOP News
FBIOP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fortress Biotech
FBIOP Financials
Key Financial Metrics (TTM)
Gross Margin
66%
Operating Margin
-1%
Net Income Margin
6%
Return on Equity
0%
Return on Capital
-73%
Return on Assets
2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
16.65%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
15.03K
Short Interest
0.00%
Avg. Volume
26.53K
Financials (TTM)
Gross Profit
$36.80M
Operating Income
$110.38M
EBITDA
$104.49M
Operating Cash Flow
$80.19M
Capital Expenditure
$15.00M
Free Cash Flow
$95.19M
Cash & ST Invst.
$57.26M
Total Debt
$75.96M
Fortress Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$17.63M
+20.5%
Gross Profit
$11.88M
+27.1%
Gross Margin
67.36%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
101
N/A
Net Income
$5.85M
+145.5%
EBITDA
$12.43M
+159.0%
Quarterly Fundamentals
Net Cash
$17.93M
+241.4%
Accounts Receivable
$18.13M
+67.1%
Inventory
$11.82M
+0.3%
Long Term Debt
$60.54M
-10.7%
Short Term Debt
$7.75M
+106.0%
Return on Assets
2.20%
N/A
Return on Invested Capital
-72.99%
N/A
Free Cash Flow
$6.11M
+69.5%
Operating Cash Flow
$6.11M
+69.5%